Dissemin is shutting down on January 1st, 2025

Published in

Elsevier, Current Opinion in Pharmacology, 4(5), p. 438-443

DOI: 10.1016/j.coph.2005.02.004

Links

Tools

Export citation

Search in Google Scholar

Soluble T cell receptors: Novel immunotherapies

Journal article published in 2005 by Peter E. Molloy, Andrew K. Sewell ORCID, Bent K. Jakobsen
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

T cell receptors are antigen-specific proteins that have evolved to recognize peptide antigens presented by human leukocyte antigen molecules on most cell types. Like antibodies, T cell receptors are produced with huge diversity but, unlike antibodies, T cell receptors are not secreted and do not undergo somatic mutations that increase their affinities for antigen. Recently, however, methods have been developed that enable T cell receptors to be engineered as soluble proteins with extremely high affinities, and fused to various immune-modulator molecules. T cell receptors are now set to unlock a whole new range of targets with key roles in cancer, viral infections, autoimmune diseases and allergies.